Showing results (991-1000 of 1,169) with videos related to

Sort By:
Pageof 117
Journal of Experimental & Clinical Cancer Research : CR|May 5, 2022
EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathwayYachong Liu, Jia Song, Hongwei Zhang, et al.
Journal of Virology|November 16, 2012
Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individualsAiping Qin, Weiping Cai, Ting Pan, et al.
Diabetes, Obesity & Metabolism|January 3, 2024
Influence of a diet and/or exercise intervention on long-term mortality and vascular complications in people with impaired glucose tolerance: Da Qing Diabetes Prevention Outcome studyLiping Yu, Jinping Wang, Qiuhong Gong, et al.
Cell Research|December 21, 2011
TRPV1 activation improves exercise endurance and energy metabolism through PGC-1α upregulation in miceZhidan Luo, Liqun Ma, Zhigang Zhao, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
4-Aryl Pyrrolidines as Novel Orally Efficacious Antimalarial Agents. Part 2: 2-Aryl-<i>N</i>-(4-arylpyrrolidin-3-yl)acetamidesMarvin J Meyers, Jianguang Liu, Zhijun Liu, et al.
Frontiers in Pharmacology|April 12, 2019
Polytropic Influence of <i>TRIB3</i> rs2295490 Genetic Polymorphism on Response to Antihypertensive Agents in Patients With Essential HypertensionJiecan Zhou, Fazhong He, Bao Sun, et al.
Pathology, Research and Practice|February 4, 2020
Upregulation of DEAD box helicase 5 and 17 are correlated with the progression and poor prognosis in gliomasQisheng Luo, Tianshi Que, Hongcheng Luo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 17, 2015
Simulated microgravity disrupts intestinal homeostasis and increases colitis susceptibilityPingping Li, Junxiu Shi, Peng Zhang, et al.
Plos One|October 31, 2012
Changes in the diurnal rhythms during a 45-day head-down bed restXiaodi Liang, Lin Zhang, Yufeng Wan, et al.
Trials|November 29, 2023
The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}Mengzhuo Xu, Xin Zhang, Runyu Ye, et al.
Pageof 117